118th Congress Health
H.R. 124: Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Don Bacon R-NE
- Eleanor Norton D-DC
- Bennie Thompson D-MS
Who scored on this bill
- 1Al Green SponsorIntroduced, drew cross-party cosponsors2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Al Green
History
- Introduced in the House by Al Green.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.